Cargando…
Adaptive immune responses to SARS-CoV-2()
This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with othe...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891074/ https://www.ncbi.nlm.nih.gov/pubmed/33610693 http://dx.doi.org/10.1016/j.addr.2021.02.009 |
_version_ | 1783652629191065600 |
---|---|
author | Forthal, Donald |
author_facet | Forthal, Donald |
author_sort | Forthal, Donald |
collection | PubMed |
description | This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with other viral infections, SARS-CoV-2 elicits both antibody and T-cell responses. Whereas antibody responses are likely effective in preventing infection and may participate in controlling infection once established, it is less clear whether or not they play a role in pathogenesis. T cells are likely involved in controlling established infection, but a pathogenic role is also possible. Longer term evaluation is necessary to determine the durability of protective immune responses. |
format | Online Article Text |
id | pubmed-7891074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78910742021-02-19 Adaptive immune responses to SARS-CoV-2() Forthal, Donald Adv Drug Deliv Rev Article This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with other viral infections, SARS-CoV-2 elicits both antibody and T-cell responses. Whereas antibody responses are likely effective in preventing infection and may participate in controlling infection once established, it is less clear whether or not they play a role in pathogenesis. T cells are likely involved in controlling established infection, but a pathogenic role is also possible. Longer term evaluation is necessary to determine the durability of protective immune responses. Elsevier B.V. 2021-05 2021-02-18 /pmc/articles/PMC7891074/ /pubmed/33610693 http://dx.doi.org/10.1016/j.addr.2021.02.009 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Forthal, Donald Adaptive immune responses to SARS-CoV-2() |
title | Adaptive immune responses to SARS-CoV-2() |
title_full | Adaptive immune responses to SARS-CoV-2() |
title_fullStr | Adaptive immune responses to SARS-CoV-2() |
title_full_unstemmed | Adaptive immune responses to SARS-CoV-2() |
title_short | Adaptive immune responses to SARS-CoV-2() |
title_sort | adaptive immune responses to sars-cov-2() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891074/ https://www.ncbi.nlm.nih.gov/pubmed/33610693 http://dx.doi.org/10.1016/j.addr.2021.02.009 |
work_keys_str_mv | AT forthaldonald adaptiveimmuneresponsestosarscov2 |